This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Hypnosis vs Midazolam for Sedation for TEE

This study has been completed.
Information provided by (Responsible Party):
Bakirkoy Dr. Sadi Konuk Research and Training Hospital Identifier:
First received: December 12, 2012
Last updated: February 27, 2013
Last verified: February 2013
Most of the reports on hypnosis in the literature have focused on pain control during minor operations. With this study we aimed to evaluate the role of hypnosis on sedation for transesophageal echocardiography and compare it with commonly used sedative midazolam.

Condition Intervention
Clinical Indications for Transesophageal Echocardiography Drug: Midazolam Other: hypnotherapy

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Hypnosis for Sedation in Transesophageal Echocardiography: Comparison With Midazolam

Resource links provided by NLM:

Further study details as provided by Bakirkoy Dr. Sadi Konuk Research and Training Hospital:

Primary Outcome Measures:
  • Sedative effects of hypnotherapy and the drug "midazolam" indicated by anxiety scores and bispectral index (BIS) monitoring [ Time Frame: during transesophageal echocardiography ]

Secondary Outcome Measures:
  • measurement of alertness after sedation with continuous performance test (CPT) [ Time Frame: the same time frame ]

Enrollment: 98
Study Start Date: June 2010
Study Completion Date: September 2010
Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
midazolam Drug: Midazolam
The patients will be given 0.05mg/kg iv midazolam just before monitorization. During probing, in case of intolerance to the insertion of the probe, the increments of midazolam with 0.005mg/kg doses will be given.
hypnosis Other: hypnotherapy
A first hypnotic induction will be carried out the day before the procedure, next day, fifteen minutes before the procedure, a new induction will be performed.


Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
patients admitting to cardiology department for transesophageal echocardiography (TEE)

Inclusion Criteria:

  • indications for TEE
  • American Society of Anesthesiology (ASA) physical status I-III

Exclusion Criteria:

  • mental illness,
  • psychotropic medication use,
  • hypersensitivity to drugs
  • a body mass index over 30.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01749475

Bakirkoy Dr Sadi Konuk Training Hospital
Istanbul, Turkey
Sponsors and Collaborators
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
  More Information

Responsible Party: Bakirkoy Dr. Sadi Konuk Research and Training Hospital Identifier: NCT01749475     History of Changes
Other Study ID Numbers: HYPTEE
Study First Received: December 12, 2012
Last Updated: February 27, 2013

Additional relevant MeSH terms:
Adjuvants, Anesthesia
Hypnotics and Sedatives
Central Nervous System Depressants
Physiological Effects of Drugs
Anti-Anxiety Agents
Tranquilizing Agents
Psychotropic Drugs
Anesthetics, Intravenous
Anesthetics, General
GABA Modulators
GABA Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action processed this record on September 21, 2017